Literature DB >> 25343817

Acute kidney injury: gateway to chronic kidney disease.

Michael Heung1, Lakhmir S Chawla.   

Abstract

This review examines the evidence linking acute kidney injury (AKI) with the risk of subsequently developing chronic kidney disease (CKD). The discussion focuses on subjects that recover from an episode of AKI, most of whom do not receive follow-up nephrology care. Many recent studies have shown a strong association between AKI and the risk of developing CKD. Preclinical models provide evidence for a causal link between AKI and CKD while also proposing some of the potential mechanisms for this progression. Large observational studies have begun to quantify the risk for CKD following AKI recovery and identify risk factors for the development of CKD. In summary, there is an association between AKI with incomplete recovery or lack of recovery and CKD. Multiple studies now suggest that even AKI with apparent full recovery confers an independent risk for later development of CKD. Severity of AKI, baseline CKD, and multiple episodes of AKI remain consistent risk factors for CKD after AKI. The proposed risk prediction models that have been developed require further refinement and validation. The identification of patients with AKI recovery who are at high risk for later CKD development remains an important clinical and research goal. 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25343817     DOI: 10.1159/000363675

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  15 in total

1.  Mouse Models of Kidney Fibrosis.

Authors:  Rafael Kramann; Sylvia Menzel
Journal:  Methods Mol Biol       Date:  2021

2.  Ultrasound super-resolution imaging provides a noninvasive assessment of renal microvasculature changes during mouse acute kidney injury.

Authors:  Qiyang Chen; Jaesok Yu; Brittney M Rush; Sean D Stocker; Roderick J Tan; Kang Kim
Journal:  Kidney Int       Date:  2020-03-03       Impact factor: 10.612

3.  Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.

Authors:  Jeffrey D Pressly; Suni M Mustafa; Ammaar H Adibi; Sahar Alghamdi; Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen; Bob M Moore; Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2017-11-29       Impact factor: 4.030

4.  Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury.

Authors:  Beom Jin Lim; Jae Won Yang; Jun Zou; Jianyong Zhong; Taiji Matsusaka; Ira Pastan; Ming-Zhi Zhang; Raymond C Harris; Hai-Chun Yang; Agnes B Fogo
Journal:  Kidney Int       Date:  2017-07-12       Impact factor: 10.612

5.  The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells.

Authors:  Tess V Dupre; Dorea P Jenkins; Robin C Muise-Helmericks; Rick G Schnellmann
Journal:  Biochem Pharmacol       Date:  2019-09-19       Impact factor: 5.858

6.  PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

Authors:  Prasad Devarajan; John Lynn Jefferies
Journal:  Prog Pediatr Cardiol       Date:  2016-06

7.  A translational model of chronic kidney disease in swine.

Authors:  Alejandro R Chade; Maxx L Williams; Jason Engel; Erika Guise; Taylor W Harvey
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-25

8.  Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.

Authors:  Filiz Mercantepe; Tolga Mercantepe; Atilla Topcu; Adnan Yılmaz; Levent Tumkaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

9.  Long-term effects of COVID-19 on kidney function - Authors' reply.

Authors:  Lixue Huang; Xiaoying Gu; Yeming Wang; Chaolin Huang; Bin Cao
Journal:  Lancet       Date:  2021-05-15       Impact factor: 79.321

10.  Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease.

Authors:  Jennifer R Charlton; Yanzhe Xu; Teresa Wu; Kim A deRonde; Jillian L Hughes; Shourik Dutta; Gavin T Oxley; Aleksandra Cwiek; Helen P Cathro; Nathan P Charlton; Mark R Conaway; Edwin J Baldelomar; Neda Parvin; Kevin M Bennett
Journal:  Kidney Int       Date:  2020-09-08       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.